Infection News

More than half of a cohort of patients with rheumatic or musculoskeletal diseases reported experiencing some post-traumatic stress outcomes during the COVID-19 pandemic, according to data presented at the EULAR 2022 Congress.

In the early days of the COVID-19 pandemic, a lack of data and sure knowledge left many in the rheumatic disease sphere — health care providers and patients alike — in the dark.

DESTIN, Fla. — Adjustments made to the dosing and administration of immunomodulatory drugs may not have much impact on COVID-19 vaccine immunogenicity among patients with autoimmune and inflammatory rheumatic disease, according to data.

A two-dose vaccine course is “highly effective” against COVID-19 infection and severe outcomes in patients with rheumatoid arthritis, ankylosing spondylitis, psoriasis and inflammatory bowel disease, according to data.

DESTIN, Fla. — All patients who are immunocompromised should be educated about how to recognize COVID-19 infection early and when to report to the emergency room, according to Leonard H. Calabrese, DO, at the Congress of Clinical Rheumatology East.

Anti-inflammatory medications like steroids at hospital discharge may reduce post-acute infection mortality risk in patients who experienced hyperinflammation from severe COVID-19, according to data published in Frontiers in Medicine.

The FDA has approved a new indication for Olumiant as a treatment for adults hospitalized with COVID-19 who require supplemental oxygen, noninvasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.

Patients with gout demonstrate an increased risk for COVID-19-related death, with a greater burden in those with female vs. male sex, according to data published in The Lancet Rheumatology.

DENVER — The interleukin-1 inhibitor anakinra has little to no effect on moderate to severe multisystem inflammatory syndrome in children, according to researchers.

Influenza vaccination coverage in adults with early rheumatoid arthritis in Canada remains “suboptimal,” according to data published in ACR Open Rheumatology.